Glucometrix Pharma AG

Company

    • Company type:
      • Manufacturer
      • Research & Development
    • Year founded:
    • 2001
    • Employees (at the site):
    • 16
    • Turnover range:
    • 5m - <10m EUR
    • Products/services:
    • Projects: 1. Development of recombinant insulin; Conditions for a production of insulin have been completed since November 2007; 2. Treatment of diabetics' wounds with oxygen free radicals; 3. Early diagnosis of diabetes mellitus (the hardware and software should be introduced in May, 2008; Marketable as of June, 2008; 4. Non invasive blood sugar measurement; This laboratory apparatus is developed together with institutes and international universities; The prototype should be presented to the general public in the first quarter of 2009

    • Core competencies:
    • not available

    • Language skills:
    • Chinese
      English
      French
      German
      Russian
    • Key Tech / section:
      • Biotechnology: Tissue engineering and regenerative medicine
      • Medical Technology: Implants, biomaterials, tissue engineering
      • Medical Technology: Medical and electro-medical instruments and devices
    • Industries NACE:
      • 72.11: Research and experimental development on biotechnology
    • Certification:
    • not available

    • Sales markets - target industries:
    • not available
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Peter Paul Schikora (Mr.)
      - Management

      Dr. Sophia Ponomarenko (Mrs.)
      - Research & development